1015-P: Cost of Diabetes Complications in U.S. Adults Aged 65 Years or Older
| العنوان: | 1015-P: Cost of Diabetes Complications in U.S. Adults Aged 65 Years or Older |
|---|---|
| المؤلفون: | Giuseppina Imperatore, Linda J. Andes, Hui Shao, Yu Wang, Ping Zhang |
| المصدر: | Diabetes. 70 |
| بيانات النشر: | American Diabetes Association, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Pediatrics, medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Diabetes mellitus, Internal Medicine, medicine, business, medicine.disease |
| الوصف: | This study estimated the cost associated with 17 diabetes complications and treatment procedures (hypoglycemia, ketoacidosis, photocoagulation, retinopathy intravitreal injections, nephropathy, dialysis, kidney transplantation, neuropathy, foot ulcer, lower-extremity amputation, retinopathy, blindness, congestive heart failure, myocardial infarction, stroke, angina, revascularization) among US Medicare beneficiaries. Data were from 100% Medicare fee-for-service claims from 2006 to 2017. ICD 9, ICD 10, and diagnosis-related group codes were used to identify persons ≥65 years old with diabetes by type and diabetes complications. We used a longitudinal cohort design in which persons with diabetes were followed from the index year until death, exiting the health plan, or December 31, 2017, whichever came first. The index year was the year when diabetes code first appeared in inpatient claims, or in outpatient claims combined with another diabetes claim in the following 2 years. We used person-level fix-effect regression models to estimate the cost of each complication in the year when the event occurred and the follow-up years for non-acute complications. All costs were standardized to 2017 dollars. Our study included 11,028,910 patients with type 2 diabetes (T2D) and 195,546 with type 1 diabetes (T1D) in 10 cohorts. The follow-up times of the 10 cohorts ranged from 3 to 10 years. Costs of the diabetes complications varied from $375 to $ 86,639. The top three costliest complications were kidney transplantation (T2D: year of occurrence $86,639 vs. following years $15,898, T1D: $78,684 vs. $8,545), dialysis (T2D: $63,079 vs. $42,751, T1D: $60,772 vs. $43,214), and lower-extremity amputation (T2D: $45,142 vs. $8,079, T1D: $44,813 vs. $8,025). Our cost estimates provide the cost parameter needed by type 1 and type 2 diabetes simulation models and by economic evaluation of efforts to prevent/delay diabetes complications. Disclosure Y. Wang: None. P. Zhang: None. H. Shao: Research Support; Self; Sanofi. L. J. Andes: None. G. Imperatore: None. |
| تدمد: | 1939-327X 0012-1797 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::9d46b08d05055d7e85e59e4fac0e84e6 https://doi.org/10.2337/db21-1015-p |
| حقوق: | CLOSED |
| رقم الأكسشن: | edsair.doi...........9d46b08d05055d7e85e59e4fac0e84e6 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 1939327X 00121797 |
|---|